Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression

S Saxena, AL Brody, ML Ho, S Alborzian… - Archives of general …, 2002 - jamanetwork.com
Background Serotonin reuptake inhibitors (SRIs) effectively treat both major depressive
disorder (MDD) and obsessive-compulsive disorder (OCD). We compared and contrasted …

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression

S Saxena, AL Brody, ML Ho, N Zohrabi… - American Journal of …, 2003 - Am Psychiatric Assoc
OBJECTIVE: Serotonin reuptake inhibitor (SRI) medications are effective in the treatment of
both major depressive disorder and obsessive-compulsive disorder (OCD), but it is unknown …

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder

S Saxena, AL Brody, KM Maidment, JJ Dunkin… - …, 1999 - Elsevier
Previous positron emission tomography (PET) studies of patients with obsessive-compulsive
disorder (OCD) have found elevated glucose metabolic rates in the orbitofrontal cortex …

Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline

JI Lissemore, D Sookman, P Gravel, A Berney… - Translational …, 2018 - nature.com
Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are
both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet …

Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently

S Saxena, AL Brody, ML Ho, S Alborzian, MK Ho… - Biological …, 2001 - Elsevier
Background: The frequent comorbidity of major depressive disorder (MDD) and obsessive-
compulsive disorder (OCD) suggests a fundamental relationship between them. We sought …

Brain metabolic changes in major depressive disorder from pre-to post-treatment with paroxetine

AL Brody, S Saxena, DHS Silverman… - Psychiatry Research …, 1999 - Elsevier
Functional brain imaging studies of subjects with Major Depressive Disorder (MDD) have
suggested that decreased dorsolateral (DLPFC) and increased ventrolateral (VLPFC) …

Cerebral blood flow in obsessive–compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non …

R Hoehn-Saric, TE Schlaepfer, BD Greenberg… - Psychiatry Research …, 2001 - Elsevier
We examined the effects of sertraline and of desipramine on patients with OCD and
comorbid major depressive episodes at study entry. Sixteen patients, 9 receiving sertraline …

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder

AL Brody, S Saxena, JM Schwartz, PW Stoessel… - Psychiatry Research …, 1998 - Elsevier
In subjects with obsessive-compulsive disorder (OCD), lower pre-treatment metabolism in
the right orbitofrontal cortex (OFC) and anterior cingulate gyrus (AC) has been associated …

Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study

MS Buchsbaum, E Hollander… - International Journal …, 2001 - academic.oup.com
The regional metabolic effects of fluoxetine were examined in patients with autism spectrum
disorders. Six adult patients with DSM-IV and Autism Diagnostic Interview (ADI) diagnoses …

The caudate nucleus in obsessive—compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study

ES Hansen, S Hasselbalch, I Law… - International Journal of …, 2002 - academic.oup.com
Several neuroimaging studies of patients with OCD have pointed to basal ganglia and the
frontal cortical regions being relevant for an understanding of the pathophysiology and …